financetom
Business
financetom
/
Business
/
How Trump's tariffs might affect commodity and energy sectors
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
How Trump's tariffs might affect commodity and energy sectors
Feb 2, 2025 7:49 PM

(Reuters) - U.S. President Donald Trump slapped Canada and Mexico with duties of 25% and China with a 10% levy on Saturday, calling the measures necessary to combat illegal immigration and the drug trade.

Canada and Mexico immediately vowed retaliatory measures, and China said it would challenge Trump's levies at the World Trade Organization and take other countermeasures.

Trump's move has sparked volatility in the commodities market. Here are some reactions to the news:

GOLDMAN SACHS

"We still expect Canadian oil producers to eventually bear most of the burden of the tariff with a $3 to $4 a barrel wider-than-normal discount on Canadian crude given limited alternative export markets, with U.S. consumers of refined products bearing the remaining $2 to $3 a barrel burden.

"We estimate Canadian natural gas exports to the U.S. might drop by a modest 0.16 billion cubic feet per day (bcfd) as a result of 10% import tariffs, with little if any impact on U.S. gas prices."

BARCLAYS

"It would be fair to assume that all the three parties in the supply chain  will bear the incremental cost equally.

"Tariffs in general are not good for oil because they weigh on demand and boost the U.S. dollar, so we would feel more comfortable positioning for a narrower Brent-WTI spread."

CITI

"We see further tariff escalation as bullish for gold to $3,000 per ounce and silver to $36 per ounce on a 6-12 months basis and bearish copper to $8,500 per ton over the next three months, on an ex-U.S. price basis."

JP MORGAN

"We maintain our tactically bearish stance on base metals in the near term and see LME 3M copper prices at risk of falling towards $8,500/mt while LME 3M aluminum could move lower towards $2,400/mt amid a near-term pricing in of risk premium given the ramped up economic and inflationary risks of tariffs.

"For silver, platinum and palladium, the hit to industrial sentiment and threat to the automotive sector could drive a sharper divergence with gold in the near term, keeping our bullish preference primarily in gold for the time being."

RBC CAPITAL MARKETS

"Tariffs are highly unlikely to lower U.S. gas prices, and we believe these tariffs could lead to mildly higher U.S. gas prices than would otherwise be the case over the near and medium term as long as they are in effect.

"If tariffs broaden further, it simply means that gold will cost more in the U.S. than it otherwise would."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Merck Says First Patient Dosed in Phase 3 Study of Ifinatamab Deruxtecan
Merck Says First Patient Dosed in Phase 3 Study of Ifinatamab Deruxtecan
May 26, 2025
07:51 AM EDT, 05/19/2025 (MT Newswires) -- Merck ( MRK ) said Monday it has dosed the first patient in a phase 3 study assessing ifinatamab deruxtecan against chemotherapy in patients with unresectable advanced or metastatic esophageal squamous cell carcinoma with disease progression after treatment with a platinum-containing systemic therapy and an immune checkpoint inhibitor. The company said ifinatamab deruxtecan...
Zai Lab Receives US FDA Fast-Track Designation for Potential Small Cell Lung Cancer Treatment
Zai Lab Receives US FDA Fast-Track Designation for Potential Small Cell Lung Cancer Treatment
May 26, 2025
07:48 AM EDT, 05/19/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said Monday that the US Food and Drug Administration has granted fast-track designation to ZL-1310, the company's potential antibody-drug conjugate for the treatment of extensive-stage small cell lung cancer. The drug, currently being evaluated in a phase 1 clinical trial already received an FDA orphan drug designation for...
Top Premarket Decliners
Top Premarket Decliners
May 26, 2025
07:53 AM EDT, 05/19/2025 (MT Newswires) -- Mainz Biomed ( MYNZ ) shares fell 18% pre-bell Monday following a 6.6% increase in the previous session. Forte Biosciences ( FBRX ) shares dropped 15% following a muted session. Capstone Holding (CAPS) stock was down 13%, paring gains from Friday. Lichen International ( LICN ) shares retreated 12%, cutting Friday's rally. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved